Volume 16, Issue 2, March 2022

Index

REVIEW ONCOLOGY

Doublets in the first-line treatment of metastatic renal cell cancer with clear cell histology

D. Schrijvers, S. Van Wambeke, W. Teurfs


Is there a place for thromboprophylaxis in cancer patients?

A. Awada, K. Jochmans, C. Vulsteke, T. Vanassche, J. Mebis, V. Mathieux, J-F. Baurain, P. Hainaut, P. Verhamme


PRACTICE GUIDELINES

Update to the Belgian follow-up guidelines for abnormal cervical screening results

C. Bourgain, B. Weynand, K. Van de Vijver, S. Shahebali


HEALTHCARE

Relationship between volume and outcome in lung cancer

D. Verhoeven, P. Bogaerts, P. Bernaerts, W. Demey


ONCOCASE

Capecitabine and folic acid: A lethal combination?

D. Naudts, L-A. Teuwen, J. Van Boven, H. Prenen, T. Vandamme, B. Van Overberghe, K. Forceville, M. Peeters


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

T. Feys


X